(Q40637657)

22 September 2017

Philadelphia chromosome-positive acute lymphoblastic leukemia- current concepts and future perspectives (English)

1 reference

22 September 2017

1 reference

4

Hagop M Kantarjian

1 reference

22 September 2017

1

Stefan Faderl

1 reference

PubMed ID

12196213

22 September 2017

Guillermo Garcia-Manero

series ordinal

2

object named as

Guillermo Garcia-Manero

1 reference

22 September 2017

Deborah A Thomas

3

1 reference

22 September 2017

1 June 2002

1 reference

Reviews in Clinical and Experimental Hematology

22 September 2017

1 reference

22 September 2017

6

1 reference

22 September 2017

2

1 reference

22 September 2017

142-60; discussion 200-2

1 reference

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

22 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

The Philadelphia Chromosome (Ph1) in Adults Presenting with Acute Leukaemia: a Comparison of Ph1+ and Ph1- Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

Ph positive acute lymphoblastic leukemia in adults: molecular and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

The biology of chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

The molecular genetics of Philadelphia chromosome-positive leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

Complex chromosome 9, 20, and 22 rearrangements in acute lymphoblastic leukemia with duplication of BCR and ABL sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

Philadelphia-positive B-cell acute lymphoblastic leukemia is initiated in an uncommitted progenitor cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

p210 Bcr-Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

A bcr-v-abl oncogene induces lymphomas in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

Acute leukaemia in bcr/abl transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

The clinical significance of detection of residual disease in childhood ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

Clinical and prognostic significance of the Philadelphia chromosome in adult patients with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

Allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

STAT3 is constitutively activated in Hodgkin cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2002.00066.X

10.1046/J.1468-0734.2002.00066.X

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

12196213